COVID-19 Vaccine

Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases

Technical Competitivity

Rapid Response platform for combating COVID-19 variants

The adenovirus vector platform we have built is optimized for fast and massive production of vaccines.
Therefore, it is possible to respond quickly to different COVID-19 variants.

Scroll left and right to read.